Although ALB and GLB can be used to predict the clinical outcomes of patients with cancer 50, 51, the measurement of a single indicator may be affected by host factors, such as body fluid changes, hepatic dysfunction, and acute infection or inflammation. Here, ALB is linked to cancer.